vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Nutanix, Inc. (NTNX). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $670.6M, roughly 1.2× Nutanix, Inc.). Nutanix, Inc. runs the higher net margin — 9.3% vs 0.5%, a 8.7% gap on every dollar of revenue. On growth, Nutanix, Inc. posted the faster year-over-year revenue change (13.5% vs 7.5%). Over the past eight quarters, Nutanix, Inc.'s revenue compounded faster (8.9% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Nutanix, Inc. is an American cloud computing company that sells software for datacenters and hybrid multi-cloud deployments. This includes software for virtualization, Kubernetes, database-as-a-service, software-defined networking, security, as well as software-defined storage for file, object, and block storage.
ACHC vs NTNX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $670.6M |
| Net Profit | $4.5M | $62.1M |
| Gross Margin | — | 87.0% |
| Operating Margin | — | 7.4% |
| Net Margin | 0.5% | 9.3% |
| Revenue YoY | 7.5% | 13.5% |
| Net Profit YoY | -50.8% | 107.5% |
| EPS (diluted) | $0.05 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $670.6M | ||
| Q3 25 | $851.6M | $653.3M | ||
| Q2 25 | $869.2M | $639.0M | ||
| Q1 25 | $770.5M | $654.7M | ||
| Q4 24 | $774.2M | $591.0M | ||
| Q3 24 | $815.6M | $548.0M | ||
| Q2 24 | $796.0M | $524.6M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $62.1M | ||
| Q3 25 | $36.2M | $38.6M | ||
| Q2 25 | $30.1M | $63.4M | ||
| Q1 25 | $8.4M | $56.4M | ||
| Q4 24 | $32.6M | $29.9M | ||
| Q3 24 | $68.1M | $-126.1M | ||
| Q2 24 | $78.5M | $-15.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 87.0% | ||
| Q3 25 | — | 87.2% | ||
| Q2 25 | — | 87.0% | ||
| Q1 25 | — | 87.0% | ||
| Q4 24 | — | 86.0% | ||
| Q3 24 | — | 85.2% | ||
| Q2 24 | — | 84.8% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 7.4% | ||
| Q3 25 | 4.7% | 4.8% | ||
| Q2 25 | 5.8% | 7.6% | ||
| Q1 25 | 1.7% | 10.0% | ||
| Q4 24 | 4.9% | 4.6% | ||
| Q3 24 | 12.1% | -2.2% | ||
| Q2 24 | 13.4% | -2.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 9.3% | ||
| Q3 25 | 4.3% | 5.9% | ||
| Q2 25 | 3.5% | 9.9% | ||
| Q1 25 | 1.1% | 8.6% | ||
| Q4 24 | 4.2% | 5.1% | ||
| Q3 24 | 8.4% | -23.0% | ||
| Q2 24 | 9.9% | -3.0% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.21 | ||
| Q3 25 | $0.40 | $0.14 | ||
| Q2 25 | $0.33 | $0.22 | ||
| Q1 25 | $0.09 | $0.19 | ||
| Q4 24 | $0.36 | $0.10 | ||
| Q3 24 | $0.74 | $-0.50 | ||
| Q2 24 | $0.85 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $780.4M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $-668.6M |
| Total Assets | $5.5B | $3.3B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $780.4M | ||
| Q3 25 | $118.7M | $769.5M | ||
| Q2 25 | $131.4M | $872.6M | ||
| Q1 25 | $91.2M | $1.1B | ||
| Q4 24 | $76.3M | $716.6M | ||
| Q3 24 | $82.1M | $655.3M | ||
| Q2 24 | $77.2M | $598.0M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $-668.6M | ||
| Q3 25 | $3.1B | $-694.5M | ||
| Q2 25 | $3.1B | $-711.4M | ||
| Q1 25 | $3.0B | $-807.7M | ||
| Q4 24 | $3.1B | $-685.3M | ||
| Q3 24 | $3.0B | $-728.1M | ||
| Q2 24 | $3.0B | $-619.5M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $3.3B | ||
| Q3 25 | $6.4B | $3.3B | ||
| Q2 25 | $6.3B | $3.1B | ||
| Q1 25 | $6.1B | $3.0B | ||
| Q4 24 | $6.0B | $2.2B | ||
| Q3 24 | $5.9B | $2.1B | ||
| Q2 24 | $5.7B | $2.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $196.8M |
| Free Cash FlowOCF − Capex | — | $174.5M |
| FCF MarginFCF / Revenue | — | 26.0% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | 13.78× | 3.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | $772.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $196.8M | ||
| Q3 25 | $73.2M | $219.5M | ||
| Q2 25 | $133.5M | $218.5M | ||
| Q1 25 | $11.5M | $221.7M | ||
| Q4 24 | $116.7M | $161.8M | ||
| Q3 24 | $163.1M | $244.7M | ||
| Q2 24 | $171.1M | $96.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $174.5M | ||
| Q3 25 | $-63.0M | $207.8M | ||
| Q2 25 | $-34.2M | $203.4M | ||
| Q1 25 | $-163.2M | $187.1M | ||
| Q4 24 | $-86.8M | $151.9M | ||
| Q3 24 | $-27.1M | $224.3M | ||
| Q2 24 | $16.9M | $78.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 26.0% | ||
| Q3 25 | -7.4% | 31.8% | ||
| Q2 25 | -3.9% | 31.8% | ||
| Q1 25 | -21.2% | 28.6% | ||
| Q4 24 | -11.2% | 25.7% | ||
| Q3 24 | -3.3% | 40.9% | ||
| Q2 24 | 2.1% | 14.9% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.3% | ||
| Q3 25 | 16.0% | 1.8% | ||
| Q2 25 | 19.3% | 2.4% | ||
| Q1 25 | 22.7% | 5.3% | ||
| Q4 24 | 26.3% | 1.7% | ||
| Q3 24 | 23.3% | 3.7% | ||
| Q2 24 | 19.4% | 3.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.17× | ||
| Q3 25 | 2.02× | 5.68× | ||
| Q2 25 | 4.43× | 3.45× | ||
| Q1 25 | 1.37× | 3.93× | ||
| Q4 24 | 3.58× | 5.41× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
NTNX
| Services | $335.5M | 50% |
| Subscriptionand Circulation Software Entitlementand Support Subscription | $320.8M | 48% |
| Other | $14.3M | 2% |
